Category: Moderna

Moderna: Over 1,000 Heart Inflammation Cases in Those Under 40 Following COVID-19 Vaccination

Over 1,000 cases of heart inflammation have been detected in recipients of Moderna’s COVID-19 vaccine who are under 40 years old, the biotechnology company said on June 10. Myocarditis, a type of heart inflammation, has been most prevalent following vaccination in males 18 to 24 years old, according to the company. In a document (pdf)…


Moderna: Over 1,000 Heart Inflammation Cases in People Under 40 Following COVID-19 Vaccination

Over 1,000 cases of heart inflammation have been detected in recipients of Moderna’s COVID-19 vaccine who are under 40 years old, the biotechnology company said on June 10. Myocarditis, a type of heart inflammation, has been most prevalent following vaccination in males 18 to 24 years old, according to the company. In a document (pdf)…


Moderna Delays COVID Vaccine Deliveries to EU by Several Months

Moderna Inc. said on Thursday it has agreed to push back some COVID-19 vaccine deliveries to the European Union by several months to later in 2022 or early next year. Shares of Moderna fell nearly 2 percent before the bell over the delay, even though the company stuck to its vaccine sales forecast of $21…


Japan Study Shows Women More Likely to Get Skin Rash From Moderna Shot

TOKYO—A study in Japan found that women were significantly more likely than men to develop rash-like side effects after a first dose of Moderna Inc.’s COVID-19 vaccine. The study of 5,893 participants between May and November last year showed that 22.4 percent of women developed delayed skin reactions after the first shot, compared to 5.1…


Natural Gas Tops $9, Highest Since 2008; Will India Sugar Export Limits Impact U.S.? | NTD Business

Natural gas prices soar to a decade high today. Are we going to see higher utility bills? The world’s second largest sugar exporter is curbing exports. Will it impact the United States? A second shipment of baby formula arrives in the U.S., while the head of the FDA finds himself in the hot seat over why…


Natural Gas Tops $9, Highest Since 2008; Will India Sugar Export Limits Impact US? | NTD Business

Natural gas prices soar to a decade high. Are we going to see higher utility bills? The world’s second-largest sugar exporter is curbing exports. Will it impact the United States? A second shipment of baby formula has arrived in the United States, while the head of the FDA finds himself in the hot seat over why…


Moderna ‘Throwing 30 Million Doses in the Garbage’ Over Dwindling Vaccine Demand: CEO

The CEO of pharmaceutical and biotechnology company Moderna, Stéphane Bancel, said the company is having to “throw away” millions of doses of COVID-19 vaccines because “nobody wants them.” Bancel made the comments during an appearance at the World Economic Forum on Monday, while noting his concerns over the lack of people getting vaccinated and waning immunity among those…


Moderna ‘Throwing 30 Million Doses in the Garbage,’ CEO Says

The CEO of pharmaceutical and biotechnology company Moderna, Stéphane Bancel, said the company is having to “throw away” millions of doses of COVID-19 vaccines because “nobody wants them.” Bancel made the comments during an appearance at the World Economic Forum on Monday, while noting his concerns over the lack of people getting vaccinated and waning immunity among those…


Moderna Testing Potential Monkeypox Vaccines in Pre-Clinical Trials

Moderna Inc. said on Monday that it testing potential vaccines against monkeypox in pre-clinical trials as the disease spreads in the United States and Europe. The announcement comes as the World Health Organization (WHO) said on Tuesday that there have been 131 cases of monkeypox identified around the world, with most of them occurring in Spain, Portugal, and…


Moderna Targeting Fall Release for Omicron Variant-Specific COVID-19 Boosters

A top executive at vaccine maker Moderna said that an Omicron- and subvariant-specific COVID-19 vaccine booster will be potentially released by the company in the fall. “We announced a couple weeks ago a new, variant-specific booster that we’ve been testing, and we have an additional candidate, our lead candidate, in testing now that I believe…